We are pleased to announce that we have established a new cell culture center (CPC) in line with the expansion of production of regenerative medicine products, and after receiving permission from the Kyushu Bureau of Health and Welfare, we have begun operating the facility as shown below. The newly established CPC has a production capacity of more than 10,000 products per year, and together with the existing facility, we will continue to produce regenerative medicine products in response to increasing demand.

Outline of the new CPC

1. Facility name：Dojin CPC 2
2. Location：1-27, Ryutsu-Danchi, Minami Ward, Kumamoto, Japan
3. Facility number：FA7240001
4. Start of operation：June 2024